{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:34:47Z","timestamp":1778902487563,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.neulet.2003.12.071","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T11:29:34Z","timestamp":1079522974000},"page":"56-59","source":"Crossref","is-referenced-by-count":75,"title":["Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats"],"prefix":"10.1016","volume":"361","author":[{"given":"Yan Qi","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi Can","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2003.12.071_BIB1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s002130051082","article-title":"The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats","volume":"146","author":"Ballard","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2003.12.071_BIB2","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1021\/bi020016x","article-title":"Kinetic and structural studies on the interaction of cholinesterase with the anti-Alzheimer drug rivastigmine","volume":"41","author":"Bar-On","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.neulet.2003.12.071_BIB3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neulet.2003.12.071_BIB4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00001756-199612200-00020","article-title":"Huperzine A, a novel promising acetylcholinesterase inhibitor","volume":"8","author":"Cheng","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.neulet.2003.12.071_BIB5","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: A disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neulet.2003.12.071_BIB6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2003.12.071_BIB7","series-title":"Alzheimer Disease: Therapeutic Strategies","first-page":"1","article-title":"Development of drugs for Alzheimer therapy: a decade of progress","author":"Giacobini","year":"1994"},{"key":"10.1016\/j.neulet.2003.12.071_BIB8","series-title":"Alzheimer Disease: Therapeutic Strategies","first-page":"155","article-title":"Second and third generation cholinesterase inhibitors: from preclinical studies to clinical efficacy","author":"Giacobini","year":"1994"},{"key":"10.1016\/j.neulet.2003.12.071_BIB9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0028-3908(95)00157-3","article-title":"The effect of the selective reversible acetylcholinesterase E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex","volume":"35","author":"Giacobini","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2003.12.071_BIB10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-4347(93)80258-6","article-title":"Improved method for the routine analysis of acetylcholine release in vivo: quantitation in the presence and absence of esterase inhibitor","volume":"622","author":"Greaney","year":"1993","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.neulet.2003.12.071_BIB11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-2999(99)00545-2","article-title":"Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats","volume":"380","author":"Kosasa","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2003.12.071_BIB12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0028-3908(93)90182-3","article-title":"Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex","volume":"32","author":"Messamore","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2003.12.071_BIB13","series-title":"Cholinergic Basis for Alzheimer Therapy","first-page":"314","article-title":"E2020: the pharmacology of a piperidine cholinesterase inhibitor","author":"Rogers","year":"1991"},{"key":"10.1016\/j.neulet.2003.12.071_BIB14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s007020200090","article-title":"Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats","volume":"109","author":"Scali","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neulet.2003.12.071_BIB15","series-title":"Current Research in Alzheimer Therapy","first-page":"73","article-title":"Blood cholinesterase as a guide to the efficacy of putative therapies for Alzheimer dementia: comparison of tacrine and physostigmine","author":"Sherman","year":"1988"},{"key":"10.1016\/j.neulet.2003.12.071_BIB16","first-page":"481","article-title":"Huperzine A (Shuangyiping): A promising drug for Alzheimer's disease","volume":"17","author":"Tang","year":"1996","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neulet.2003.12.071_BIB17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1358\/dof.1999.024.06.545143","article-title":"Huperzine A: a novel acetylcholinesterase inhibitor","volume":"24","author":"Tang","year":"1999","journal-title":"Drugs Fut."},{"key":"10.1016\/j.neulet.2003.12.071_BIB18","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"161","article-title":"Anticholinesterase agents","author":"Taylor","year":"1996"},{"key":"10.1016\/j.neulet.2003.12.071_BIB19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0006-8993(00)02266-6","article-title":"In vivo neurochemical effects of the acetylcholinesterase inhibitor ENA713 in rat hippocampus","volume":"865","author":"Trabace","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2003.12.071_BIB20","first-page":"219","article-title":"Pharmacological evaluation of phenyl-carbamates as CNS-selective acetylcholinesterase inhibitors","volume":"43","author":"Weinstock","year":"1994","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neulet.2003.12.071_BIB21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-2999(02)02589-X","article-title":"Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine","volume":"455","author":"Zhao","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2003.12.071_BIB22","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jnr.490410613","article-title":"Second generation cholinesterase inhibitors: effect of (L)-huperzine-A on cortical biogenic amines","volume":"41","author":"Zhu","year":"1995","journal-title":"J. Neurosci. Res."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394003015428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394003015428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T16:20:46Z","timestamp":1550161246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394003015428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":22,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0304394003015428"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2003.12.071","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}